Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120664 · ClinicalTrials.gov registry record · Phase 1
Florbetapir Calibration to the Centiloid Scale
A Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT02120664 is a Phase 1 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 35 participants.
The verdict
NCT02120664, a Phase 1 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study is designed to demonstrate the conversion of florbetapir (18F) Positron Emission Tomography (PET) Standard Uptake Value ratio (SUVr) to Centiloid units.
Interventions
- DRUG Florbetapir (18F)
- DRUG 11C-PiB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120664
The ClinicalTrials.gov registry entry for NCT02120664 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Florbetapir (18F) is the first listed.
NCT02120664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02120664 about?
NCT02120664 is a clinical study titled "Florbetapir Calibration to the Centiloid Scale". This study is designed to demonstrate the conversion of florbetapir (18F) Positron Emission Tomography (PET) Standard Uptake Value ratio (SUVr) to Centiloid units.
What is the current status of trial NCT02120664?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2014-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02120664?
The interventions under investigation include: Florbetapir (18F) (DRUG), 11C-PiB (DRUG).
Who is sponsoring clinical trial NCT02120664?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.